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Abstract
We evaluated the hypothesis that lactate shuttling helps support the nutritive needs of injured brains. To that end, we
utilized dual isotope tracer [6,6-2H2]glucose, that is, D2-glucose, and [3-13C]lactate techniques involving arm vein tracer
infusion along with simultaneous cerebral (arterial [art] and jugular bulb [JB]) blood sampling. Traumatic brain injury
(TBI) patients with nonpenetrating brain injuries (n = 12) were entered into the study following consent of patients’ legal
representatives. Written and informed consent was obtained from control volunteers (n = 6). Patients were studied 5.7 – 2.2
(mean – SD) days post-injury; during periods when arterial glucose concentration tended to be higher in TBI patients. As
in previous investigations, the cerebral metabolic rate for glucose (CMRgluc, i.e., net glucose uptake) was significantly
suppressed following TBI ( p < 0.001). However, lactate fractional extraction, an index of cerebral lactate uptake related to
systemic lactate supply, approximated 11% in both healthy control subjects and TBI patients. Further, neither the CMR for
lactate (CMRlac, i.e., net lactate release), nor the tracer-measured cerebral lactate uptake differed between healthy
controls and TBI patients. The percentages of lactate tracer taken up and released as 13CO2 into the JB accounted for 92%
and 91% for control and TBI conditions, respectively, suggesting that most cerebral lactate uptake was oxidized following
TBI. Comparisons of isotopic enrichments of lactate oxidation from infused [3-13C]lactate tracer and 13C-glucose pro-
duced during hepatic and renal gluconeogenesis (GNG) showed that 75–80% of 13CO2 released into the JB was from
lactate and that the remainder was from the oxidation of glucose secondarily labeled from lactate. Hence, either directly as
lactate uptake, or indirectly via GNG, peripheral lactate production accounted for *70% of carbohydrate (direct lactate
uptake + uptake of glucose from lactate) consumed by the injured brain. Undiminished cerebral lactate fractional ex-
traction and uptake suggest that arterial lactate supplementation may be used to compensate for decreased CMRgluc
following TBI.
Key words: brain; fuel augmentation; glucose; lactate; mass spectrometry; stable isotopes; TBI
Introduction
Although it was once thought to be the consequence ofan inadequate oxygen supply in contracting skeletal muscle, it
is now known that lactate is continuously formed and utilized in
diverse organs, including the brain. Following traumatic brain in-
jury (TBI), lactate has long been viewed as a waste product of
oxygen-limited glycolysis and ischemia. However, both as the
product of one metabolic pathway (glycolysis), and as the substrate
for a downstream pathway (mitochondrial respiration), lactate can
be regarded as the link between glycolytic and oxidative pathways.
Importantly, as described in the lactate shuttle hypothesis, this
linkage with lactate as the vehicle of exchange can transcend
compartment barriers and occur within and between cells, tissues,
and organs.1–3
The use of lactate as a preferred fuel over glucose in brain
preparations has been observed.4,5 An astrocyte-neuron lactate
shuttle has been proposed,6,7 and neurons have a capability for
glycolysis and intracellular lactate shuttling.8,9 When blood lactate
concentration [lactate] rises in exercising humans, or when exog-
enous lactate is supplied in the vasculature, lactate is not only
the major gluconeogenic precursor,10–12 but also substitutes for
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glucose as an energy substrate in working skeletal11,13 and cardiac
muscle.14–16 Similarly, when blood lactate rises in exercising
people, or in response to injury, cerebral lactate uptake increases in
a concentration-dependent manner just as it does in working skel-
etal muscle.11,13 Also, the infusion of Na + -L-lactate has the effect
of alkalinizing the blood.17
Results showing improved cognitive function in brain-injured
rats given intravenous lactate therapy18 and rapid increases of
lactate monocarboxylate transporter (MCT) protein expression in
rat brains following TBI19 are a strong inducement for studying
lactate metabolism in humans following TBI. Because of the po-
tentially positive role for lactate in cerebral metabolism observed in
humans under diverse conditions, we undertook a study of body–
brain metabolic interaction in individuals following TBI. In our
companion article, we reported massive mobilization of body re-
sources, mainly lactate, to support hepatic and renal gluconeo-
genesis (GNG); our evidence supports that the body increases
lactate production to indirectly supply glucose to the injured
brain.24 In this work, by infusing isotopically labeled lactate, we
showed how systemic lactate was directly consumed and used by
the injured human brain. Further, as opposed to the case in which
exogenous lactate infusion could substitute for glucose in working
muscles11,13 and in the hearts of healthy men,14–16 our results sup-
ported the idea that exogenous lactate infusion could augment
cerebral substrate supply when glycolysis was diminished, as it is
following TBI.20
Methods
TBI patients
Patients were admitted to the study and medically treated as has
been described previously.20 Briefly, eligible patients included all
mechanically ventilated moderately or severely brain-injured pa-
tients, ‡ 16 years of age, who were admitted to UCLA Medical
Center within 24 h of injury. Moderate or severe brain injury was
defined as closed injury with a post-resuscitation Glasgow Coma
Score (GCS) £ 13 or deterioration to a GCS£ 13 within 24 h of
admission, and as an injury requiring mechanical ventilation and
intracranial pressure (ICP) monitoring. Exclusion criteria included
the following: 1) terminal illness (e.g., advanced cancer, AIDS); 2)
severe neurological illness (advanced Parkinson’s disease, multiple
sclerosis, Alzheimer’s dementia, disabling cerebrovascular event,
mental retardation); and 3) acute complete spinal cord injury.
UCLA and UCB institutional review boards approved this pro-
tocol, and informed consent was obtained from patients’ legal
representatives.
General management protocol
Patients were admitted to the intensive care unit (ICU) after
initial stabilization or surgical evacuation of an intracranial he-
matoma, and were treated in accordance with the Brain Trauma
Foundation and American Association of Neurological Surgeons
(AANS)/Congress of Neurological Surgeons (CNS) TBI Guide-
lines.21 Management goals included maintenance of ICP < 20 mm
Hg and cerebral perfusion pressure (CPP)> 70 mm Hg. All patients
had arterial and JB catheters inserted as soon as possible following
patient admission to allow determination of arteriovenous differ-
ences (AVD) for glucose, lactate, and oxygen.
For sampling of venous blood from the brain, the dominant
jugular vein was selected based on the dominant jugular foramen
visualized on admission CT scan. Using standard techniques, a 5 Fr
Cordis and a 4 Fr Oxymetric catheter (Baxter Critical Care, Baxter
Health Care) were inserted to a depth of*15 cm, or until resistance
was encountered. Placement of the catheter was confirmed by lat-
eral skull radiodgraphs. The catheter was calibrated in vivo, and
repeat calibration was performed every 12 h. Display of light in-
tensity and oxygen saturation was continuously displayed on the
monitor.
As a part of patient care, arterial and venous samples and
133Xenon-cerebral blood flow (CBF) studies were scheduled every
24 h during post-injury days 0–5, 7, and 9. It was not possible for all
scheduled studies to be completed on all patients because patients’
clinical status and treatments took priority, including severely el-
evated ICP (ICP > 30 mm Hg), hemodynamic and/or respiratory
instability, or removal of the jugular catheter or extubation fol-
lowing clinical improvement.
For isotope tracer studies, stable, nonradioactive D2-glucose and
[3-13C]lactate isotope tracers were infused (discussed subsequently),
typically 72–96 h after admission to the ICU when informed con-
sent had been obtained. Intravenous feeding was not used. All
glucose-containing intravenous tube feeds were discontinued be-
fore isotope infusion. Enteral feeding (Osmolite 1.2 or 1.5; Abbott
Laboratories, Abbot Park, IL) was continued during the isotope
infusion. The rate of caloric delivery was at the discretion of the
attending physician.
Healthy controls
Six healthy, nonsmoking, weight-stable volunteers (28.2 – 8.2
years) were recruited from the UCLA campus and the surrounding
community by posted notices and Internet advertisements. Subjects
were admitted into the study if they met the following criteria: 1)
had been diet and weight stable for > 6 months; 2) were not taking
medications; 3) had normal lung function, defined as forced expi-
ratory volume in 1 sec ‡ 70%; and 4) were disease and injury free as
determined by a health history questionnaire and physical exami-
nation. Control subjects received local anesthetics for catheter
placements and experimental procedures. Details for this technique
have been previously described.20 Briefly, through use of a femoral
vein approach, a JB catheter was inserted under fluoroscopic
guidance into proper position in the JB. A radial arterial line was
also placed. Again, institutional ethical review boards approved the
protocol and subjects provided written informed consent. Dietary
records were not recorded for the control group.
Experimental protocol
Control subjects reported to the laboratory and were studied as
described. Prior to tracer infusions, a blood sample was collected
from the radial artery and JB catheter for baseline isotope en-
richment measurements of glucose and lactate. Next, subjects
received a primed continuous infusion of D2-glucose and
[3-13C]lactate via an arm vein catheter while semisupine for
90 min. The priming bolus for glucose was equal to 125 times the
resting glucose infusion rate. Subsequently, D2-glucose was in-
fused at 2 mg/min. The priming bolus for lactate was equal to 23
times the resting lactate infusion rate of 2.5 mg/min.22 As previ-
ously, different tracer cocktail infusion rates were managed by
means of two separate pumps connected to a common venous
infusion port.23 Isotopes were obtained from Cambridge Isotope
Laboratories (Tewksbury, MA), diluted in 0.9% sterile saline, and
tested for sterility and pyrogenicity prior to use (UCLA Phar-
maceutical Services).
Arterial and JB blood samples (1–2 mL) were collected simul-
taneously every 60 min for a period of 3 h following commence-
ment of tracer infusion. Cannulas were flushed with an equivalent
amount of 0.9% saline after each collection.
Processing and analysis of blood
Blood samples were immediately transferred to ice-chilled
tubes containing 0.6 M of perchloric acid, shaken and stored on ice
until the end of the experiment. Within 1 h of collection, perchloric
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acid extracts were centrifuged (10 min at 3000 rpm, 2000g, 4C)
and the supernatants transferred to separate tubes for storage at
- 20C until further analysis.
Blood lactate was measured in neutralized perchloric extracts
using an enzymatic method in addition to mass spectrometry as
previously described.13,22,24 Blood lactate isotopic enrichment
(IE) was determined using gas chromatography–mass spectrometry
(GC-MS) of the N-propylamide heptafluorobutyrate derivative of
lactate.25 Briefly, neutralized perchloric extracts were lyophilized,
re-suspended in 200 ll of 2,2-dimethoxypropane and 20 ll 10%
w/w HCl in methanol, capped and incubated at room temperature
for 60 min. Next, 50 ll of N-propylamine was added and the sam-
ples were heated at 100C for 30 min, dried under a stream of N2,
re-suspended in ethyl acetate, and transferred to GC-MS vials.
Thereafter, the samples were dried under N2, derivatized by adding
20 ll of heptafluorobutyric anhydride (5 min at room temperature),
dried again under N2, and re-suspended in ethyl acetate for GC-MS
analysis. Methane was used for chemical ionization with selected
ion monitoring for mass to charge ratios 328 (unlabeled lactate) and
329 (13C-labeled lactate), respectively.
Blood glucose concentration and IE were determined by GC-MS
of the penta-acetate derivative using an Agilent DB-17 GC column
and [U-13C]glucose as internal standard. Glucose sample prepara-
tion was performed as described previously. Methane was used for
chemical ionization and selective ion monitoring was performed
for mass-to-charge ratios (M/Z) of 331, 333, and 337 for endoge-
nous glucose, D2-glucose tracer, and [U-13C6]glucose internal
standard, respectively. Selected ion abundances were compared
against external standard curves for calculation of both concen-
tration and IE, with normalization to internal standard signal for
determination of concentration.
Arterial and JB 13CO2 contents were determined by isotope ratio
mass spectrometry (IRMS) performed by Metabolic Solutions
(Nashua, NH).
Calculations
The arteriovenous differences (AVD) and cerebral metabolic
rates (CMR) of glucose and lactate were calculated as follows:
AVD (mg=dL)¼ [Metaboliteart] [MetaboliteJB]
CMR (mg=100g=min)¼AVD ·CBF
where [Metaboliteart] and [MetaboliteJB] are the concentrations of
either glucose or lactate from arterial and JB venous sites, re-
spectively, and CBF is the measured cerebral blood flow.20 Positive
AVD and CMR reflect net cerebral uptake, whereas negative AVD
and CMR indicate net cerebral release.
Tracer-measured cerebral fractional extraction (FExTM) and
tracer-measured uptake (TMU) (mg/min) were calculated as follows:
FE ·TM¼f[IELacart · [Lac]art] [IELacJB · [Lac]JB]g=
[IELacart · [Lac]art]
TMU¼CBF· FE ·TM · ½Lacart
where [Lacart] and [LacJB] are arterial and JB lactate concentra-
tions, respectively, and IELacart and IELacJB are the percent en-
richment of lactate in arterial and JB blood, respectively. Quantities
related to total lactate release include
Total cerebral lactate production (mg /min)¼TMUCMRlac
Cerebral 13CO2 production¼CBF · [(VCO2JB · IECO2JB)
 (VCO2art · IECO2JB)]
Cerebral lactate oxidation¼ (cerebral 13CO2 production)=IELacart
Lactate uptake oxidized¼ (cerebral lactate oxidation · 100)=
(TMU · 0:8)
where VCO2art and VCO2JB are the volumes of distribution of carbon
dioxide in arterial and JB blood, respectively. A correction factor for
bicarbonate retention was included and assumed to be 0.8.26, 27
Table 1. Metabolic Parameters for Traumatic Brain Injury (TBI) Patients and Healthy Controls (Mean –SE)
Parameter TBI patients Healthy controls p
CBF (mL/100g/min) 32.7 – 10.0 43.7 – 6.4 < 0.02
Sao2 (%) 98.5 – 0.6 98.1 – 0.8 0.12
SJBo2 (%) 72.2 – 3.7 66.6 – 9.4 0.12
AVD oxygen (mL/dL) 3.71 – 0.62 5.60 – 1.80 < 0.01
CMR oxygen (mL/100g/min) 1.23 – 0.35 2.45 – 0.63 < 0.001
Arterial [glucose] (mg/dL) 113.5– 32.6 107.6– 11.7 0.5
Jugular bulb [glucose] (mg/dL) 104.7– 31.8 96.2 – 10.6 0.25
Arterial glucose IE 0.010– 0.003 0.012– 0.002 0.3
Jugular bulb glucose IE 0.010– 0.004 0.012– 0.003 0.3
CMR glucose (mg/100g/min) 2.89 – 1.83 4.89 – 1.67 < 0.01
FExTM gluc 11.1 – 8.2 11.5 – 6.3 0.9
Arterial [lactate] (mg/dL) 8.44 – 2.9 10.3 – 3.6 0.4
Jugular bulb [lactate] (mg/dL) 8.74 – 2.2 10.59– 3.4 0.4
Arterial lactate IE 0.03 – 0.012 0.05 – 0.013 < 0.02
Jugular bulb lactate IE 0.025– 0.01 0.04 – 0.015 < 0.012
FExTM lac 9.72 – 10.6 9.7 – 9.1 0.9
CMR lactate (mg/100g/min) - 0.156– .31 - 0.15 – 0.0.2 0.7
TMU lactate (mg/100g/min) 0.31 – 0.42 0.49 – 0.57 0.3
Total cerebral lactate production (mg/100g/min) 0.466– .357 0.64 – 0.58 0.25
Total cerebral CHO uptake (CMRgluc +TMUlac)
(mg/100g/min)
3.20 – 2.14 5.38 – 1.37 < 0.001
CBF, cerebral blood flow; SJB ; AVD, arteriovenous differences; CMR, cerebral metabolic rates; IE, isotopic enrichment; FExTM, tracer-measured
cerebral fractional extraction; TMU, tracer-measured uptake; CHO, total carbohydrate.
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Whole body lactate and glucose rates of appearance (Ra),
rates of disappearance (Rd), and metabolic clearance rates
(MCR) were calculated using the modified equations of Steele28
for use with stable isotopes,29 and are described in our com-
panion article.24
The percent of whole body lactate Ra that was accounted for by
the brain was calculated as 100 · (total cerebral lactate release)/
(lactate Ra).
Statistical analysis
Data descriptions and testing were conducted in R version 2.15.1
(R Development Core Team, http://www.R-project.org/; R Foun-
dation for Statistical Computing, Vienna, Austria). Groups were
compared both with the conventional t test and its robust analogue,
the Yuen test,30 because of the presence of non-normality in the
data distributions31; in the text that follows, the larger of the two
p values is reported.
Results
Patient status and control subject descriptors
Demographic and anthropometric data on study participants
are provided in Table 1 of our companion article.24 Briefly, all
TBI patients were male, 35.8 – 18.8 years of age and weighed
77.6 – 11.1 kg. Mechanisms of injury for these 12 patients were
four motor vehicle accidents, four falls, two motor cycle accidents,
one pedestrian versus auto accident and one bicycle versus auto
accident. Healthy controls were (5 males and 1 female) aged
28.2 – 8.2 years of age and weighed 66.2 – 9.2 kg. Metabolic pa-
rameters are summarized in Table 1. Notable significant differences
FIG. 1. Violin plots of arterial and jugular bulb glucose (A) and
lactate concentrations (B). Solid lines represent traumatic brain
injury (TBI) patients (n = 12) whereas dashed lines are normal
control subjects (n = 6). This and subsequent figures depict the
following components: median (light circle), mean (solid line
across), interquartile range (heavy vertical bar), box-plot whisker
(thin vertical bar), and a kernel density estimation of the data
distribution (replacing the box-plot’s rectangular depiction) fol-
lowing Hintze and Nelson56 as visualized by R package ‘‘Caro-
line.’’ TBI patients are represented by the solid border, controls by
dashed lines.
FIG. 2. Violin plots of cerebral metabolic rate (CMRgluc, i.e.,
net uptake) for glucose (A) and lactate (B) (CMRlac i.e., net re-
lease). Solid lines represent traumatic brain injury (TBI) patients
(n = 12) whereas dashed lines are normal control subjects (n= 6).
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included decreased CBF, AVDO2, and CMRO2 in TBI subjects
compared with normal controls. Additionally, over the course of
measurement, arterial glucose concentration [glucoseart] was con-
stant in controls and TBI patients; the distributions of [glucoseart]
measured were not significantly different between controls and TBI
patients (Fig. 1A, Table 1). For both populations, JB glucose
concentrations [glucoseJB] were significantly lower ( p= 0.001)
than arterial values, reflecting cerebral net glucose uptake. Despite
the tendency for higher arterial glucose in TBI Patients, CMRgluc
was depressed compared with normal controls ( p < 0.001) (Fig. 2A,
Table 1).
Within 30 min of the commencement of tracer infusion, D2-
glucose isotopic enrichments were constant in jugular and arterial
blood in control subjects and TBI patients (Fig. 3). Confirming the
absence of cerebral glucose production for both populations, there
were no significant differences in IEs of simultaneously sampled
glucose in arterial and JB blood (Fig. 3). Tracer-measured frac-
tional cerebral glucose extraction (FExTM) (mean& 11%), was
not different between control subjects and TBI patients (Fig. 4A,
Table 1). Further, TMUgluc did not differ significantly between
healthy controls and TBI patients (Fig. 5A).
Arterial lactate [lactateart] was constant in controls, and constant
but slightly depressed following TBI (Fig. 1B). The lower blood
lactate levels following TBI reflect these patients’ status as patients
in the ICU 72–96 h post-injury after the initial post-injury stage of
cerebral and corporal hyperglycolysis had passed. Based on pre-
vious experience, hyperglycolysis immediately after injury raises
circulating [lactate].32 Nonetheless, higher lactate concentrations
obtained from the JB compared with those obtained from the artery
indicated cerebral lactate net release in both control subjects and
TBI patients, with no difference between the two groups (Fig. 2B,
Table 1). In contrast to CMRgluc, CMRlac was not different between
control subjects and TBI patients.
Within 30 min of the commencement of tracer infusion, [3-13C]-
lactate isotopic enrichments were constant in jugular and arterial
blood in control subjects and TBI patients. For both patient and
control populations, [3-13C]-lactate IEs were significantly lower
( p< 0.02) over the period of study in simultaneously sampled JB
blood than in arterial blood, because of the presence of net cerebral
lactate release (Fig. 2B) from significant cerebral lactate produc-
tion. Importantly, although constant over time, arterial lactate IEs
were significantly lower in TBI patients, indicating significantly
increased systemic lactate production (Ra) and removal (Rd) rates
following TBI (Table 1).24
In addition to the presence of net cerebral lactate release in both
controls and TBI patients, active cerebral lactate metabolism was
indicated by notable (* 10%) fractional extraction of lactate tracer
(FExTM) from blood traversing the brain (Fig. 4B). Tracer-mea-
sured lactate uptake was similar in healthy controls and TBI pa-
tients (Fig. 5B). Knowing that cerebral lactate uptake occurred
simultaneously with cerebral lactate release allowed calculation of
the components of cerebral lactate turnover, which were the sum of
uptake and release (Fig. 6). Inherent in calculation of cerebral
lactate uptake are components of fractional extraction (Fig. 5) and
arterial lactate delivery which, in turn, contains components of
arterial [lactate] and CBF (Fig. 1B, Table 1). TMU, and hence total
cerebral lactate production rates were not significantly different
from control values following TBI (Fig. 6).
In addition to tracer extraction (TMU), another measure of
carbohydrate metabolism is release of 13CO2 (Fig. 7). Cerebral
release of 13CO2 did not reach an asymptote over a 3 h course of
study. The delayed release of 13CO2 reflects retention in tissue
H2CO3 - HCO3
- pools.26, 27
Discussion
Summary
The major findings of this study were that cerebral lactate uptake
is not significantly diminished by TBI. Additionally, lactate that is
taken up by the brain is oxidized to CO2; however, TBI did reduce
overall cerebral carbohydrate oxidation; that is, the combined
contributions of glucose and lactate to brain substrate supply
FIG. 3. Violin plots of arterial and jugular bulb glucose isotopic enrichments. Glucose isotopic enrichments do not change as blood
courses through the brain. Lower blood glucose isotopic enrichments following trauma indicate greater peripheral glucose turnover.
Solid lines represent traumatic brain injury (TBI) patients (n = 12) whereas dashed lines are normal control subjects (n = 6).
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(CMRCHO =TMUgluc +TMUlac). This work proves definitively that
the injured human brain can utilize substrates other than glucose,
and that non-glucose metabolism may convey an advantage to the
recovering brain because glucose uptake and use is diminished
following severe injury.20
Lactate and TBI
Lactate has been considered a dead-end waste product of dis-
ordered metabolism. This view has changed over the last 30 years,
particularly with the introduction of the lactate shuttle concept.1–3
Although no longer assumed to simply be a waste product, cerebral
lactate accumulation and lactic acidosis have been considered key
secondary insults and have been suggested to be potential causes of
delayed cell death after brain trauma and brain ischemia.33,34
Elevated cerebrospinal fluid (CSF) and JB venous lactate have been
associated with a poor outcome following TBI.35 High lactate
levels are regarded as an important marker of cerebral ischemia in
arteriovenous measurements and in magnetic resonance spectros-
copy (MRS), and lactate has become a key component of neuro-
monitoring for metabolic crisis through cerebral microdialysis.
The use of high levels of cerebral lactate as a biomarker for poor
outcome are not inconsistent with results of the present investiga-
tion showing low [lactateJB], but high levels of whole-body and
cerebral lactate flux. High cerebral lactate levels measured by
MRS, microdialysis, or other methods may reflect metabolic stasis,
and the absence of metabolic flux or high lactate levels may mean
the recruitment of glycolysis to supply adenosine triphosphate
(ATP) in the face of restricted mitochondrial respiration. Based on
the present results, suffice it to say that use of a tracer is necessary to
distinguish between lactate accumulation caused by metabolic
stasis, and high production complicated by limited disposal.
Maintaining cerebral nutrient delivery is a major physiological
priority, especially following brain injury. We now show that
support for cerebral nutrient delivery is achieved by mechanisms
that operate within the brain. Also, in our companion report, we
FIG. 4. Violin plots of cerebral glucose (A) and lactate (B)
fractional extraction in healthy control subjects and traumatic
brain injury (TBI) patients. Solid lines represent TBI patients
(n = 12) whereas dashed lines are normal control subjects (n = 6).
FIG. 5. Violin plots of tracer-measured glucose (A) and lactate
uptake (B). Solid lines represent traumatic brain injury (TBI)
patients (n= 12) whereas dashed lines are normal control subjects
(n = 6).
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describe the peripheral support response by which the body serves
to fuel the brain. To review results of our companion article, sys-
temic fueling of the brain following TBI is accomplished mainly
via the mobilization of total body glycogen reserves and the pro-
duction of lactate. Lactate is the major gluconeogenic precursor
in healthy, post-absorptive individuals,10,12,36,37 and now we have
demonstrated that the role of lactate as a gluconeogenic precursor is
markedly elevated following TBI. By extension, in this report we
describe that fractional lactate uptake is maintained following TBI.
Thus, the present results offer insights not only into how the body
supports the injured brain, but also into how cerebral lactate me-
tabolism is intact and might be exogenously supported or aug-
mented following TBI.
This article has combined traditional arteriovenous differences
of cerebral metabolism with tracer-labeled substrate analyses. For
example, and as shown by equivalence of glucose isotopic en-
richments in arterial and JB blood (Fig. 3), and parity between
CMRgluc and TMUgluc (Table 1), the brain takes up and utilizes
but does not produce or release glucose as might result from GNG
or the action of debranching enzyme of 1-6 glycosidic linkages.
Hence, tracer-measured glucose uptake and CMRgluc are equal
because cerebral glucose production is zero. However, the human
brain, healthy or traumatized, both takes up and produces lactate.
Hence, total cerebral lactate production (alternatively, lactate me-
tabolism or turnover) involves components of uptake (TMUlac) and
release (CMRlac).
As with other tissues studied, such as muscle,13,22,38,39 heart,15,16
and lungs,40,41 it is now clear that simultaneous lactate uptake and
production are features of cerebral metabolism for both healthy and
injured populations. With the technology utilized in this study of
global cerebral metabolism, we cannot comment on cerebral
compartmentalization of lactate uptake or production. Minimally,
our data are consistent with the lactate shuttle concept: we now
show that lactate produced in extracerebral tissues is delivered to
the brain, where lactate serves as an oxidizable fuel energy source;
alternatively, lactate in the systemic circulation may reach the liver
for glucose production via GNG,24 with much of the resulting
glucose subsequently taken up by the brain from the systemic cir-
culation. And, also as shown here, in the brain, glucose produced
from GNG undergoes glycolysis with substrate-level phosphory-
lation of adenosine diphosphate (ADP) for ATP production or
substrate for mitochondrial oxidation. In short, lactate shuttling is a
process that serves the brain in health and disease.
Lactate can be oxidized by the human brain
Infusion studies using the stable isotope 13C-labelled sodium-L-
lactate in resting volunteers, TBI patients, and exercising humans
have shown that lactate can be oxidized to form 13CO2.
22,42–44 In
resting volunteers, lactate accounted for approximately 9% of the
total cerebral energy expenditure (Fig. 8A), with a similar contri-
bution (* 10%) after TBI (Fig. 8B). In addition, regional studies
have shown that 13C-labelled sodium-L-lactate delivered via mi-
crodialysis directly into brain parenchyma can act as an energy
FIG. 6. Violin plots of the components of cerebral lactate me-
tabolism. Release (CMRlac), tracer-measured uptake and total
cerebral lactate production =TMU-CMRlac. Solid lines represent
traumatic brain injury (TBI) patients (n= 12) whereas dashed lines
are normal control subjects (n= 6).
FIG. 7. Violin plots of cerebral lactate oxidation in control
and traumatic brain injury (TBI) patients. Values given in
absolute (mg/100 g/min, panel A), and relative (% lactate
uptake oxidized, panel B) terms. In absolute terms, cerebral
lactate oxidation declined, but a greater percentage of uptake
was oxidized following TBI. Solid lines represent TBI pa-
tients (n = 12) whereas dashed lines are normal control sub-
jects (n = 6).
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source by measuring 13C signals in glutamine.45 Other recent
studies have shown indirectly that the brain may oxidize lactate
following TBI.46,47
In this investigation, glucose and lactate turnover rates are pre-
sented in units of mg/min (instead of mMol/min) to facilitate
comparisons between the two substrates, the necessity of continu-
ously considering the 2:1 molar ratio between lactate and glucose
being obviated. On this basis, it is clear that whereas whole-body
glucose turnover increases following TBI, the relative ( > 71%)
increase in whole-body lactate turnover is far greater than is the rise
in glucose turnover after TBI. In part, the increased systemic lactate
production is disposed of via a quadrupling of the percent GNG
following TBI.24 Following TBI, the increase in systemic lactate
appearance is far greater than the elevation in glucose disposal; we
interpret the results to mean that a carbon source, other than glu-
cose, supports the large increase in lactate production following
TBI. That source is presumed to be glycogen that not only exists in
skeletal muscle, but also in other large organ systems, such as the
integument and liver.2
Fractional lactate extraction (FExTM) is based on an accounting
of tracer lactate in JB compared with arterial blood. As blood tra-
verses the cerebral circulation, some isotopic dilution occurs as the
result of cerebral lactate production and the resulting net release of
lactate (i.e., CMRlac, Fig. 3B). However, what is not apparent in the
standard CMRlac calculation is that TMU accounts for most total
cerebral lactate production (Fig. 6). Rephrased, both injured and
control brains simultaneously produced, consumed, and oxidized
lactate. Importantly, because fractional lactate extraction was un-
affected (Fig. 4B), tracer-measured lactate uptake was not signif-
icantly depressed following TBI (Fig. 5B). One might predict
that in our studies the capacity for cerebral lactate uptake was
underestimated. Arterial [lactate] was depressed (relative to acute
FIG. 8. Histograms of the absolute and relative contributions to total cerebral carbohydrate (CHO) from lactate, glucose from
gluconeogenesis (GNG), and glucose from hepatic glycogenolysis in healthy control subjects (left, panels A and C), and traumatic brain
injury (TBI) patients (Right, panels B and D). Compared with panel A, panel B shows the decrease in cerebral metabolic rate for glucose
(CMRgluc) following TBI, but also shows increased contributions of lactate and glucose from GNG to total cerebral CHO uptake after
TBI. A comparison of panels C (control) and D (TBI) shows the large increase in percentage cerebral CHO uptake contributed by
lactate, directly, or indirectly from GNG, following TBI.
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post-injury times) in the TBI patients whom we studied 72–96
hours after injury, and, also, CBF was suppressed (Table 1). Our
data predict that augmentations in either or both arterial [lactate]
and CBF could increase cerebral lactate uptake, and thus provide
nutritive support to the traumatized brain.
In our investigation, we compared 13C-TMU for lactate
with the difference between JB and arterial 13CO2 contents. For
control subjects, lactate oxidation approximated 0.4 mg/100 g/
min, of which excretion as 13CO2 in JB approximated 92% of
uptake (Fig. 7A and B, respectively). Following TBI, CMRO2
was decreased (Table 1), as was the 13C-TMU for lactate. For
TBI patients, lactate oxidation approximated 0.3 mg/100 g/min
(Fig. 7A), of which excretion as 13CO2 in jugular bulb ap-
proximated 91% after injury. Therefore, even though CMRO2
was suppressed following TBI (Table 1), cerebral lactate oxi-
dation was nearly complete in both controls and TBI patients
(Fig. 7A and B, respectively).
Interpretation of cerebral lactate oxidation data is complicated
in this investigation by extreme efforts of the peripheral lactate
producing and gluconeogenic organs that, in concert, act to pro-
vide nutritive support to the injured brain via lactate shuttling
(described previously). Peripheral glycogenolysis raises systemic
lactate production by nearly 100%, which provides a precursor
supply sufficient to raise hepatic GNG from lactate by > 400%.
Hence, 13C exists in the arterial circulation as infused 13C-labeled
lactate, and also as glucose, secondarily labeled carbon by GNG
from lactate.24
In our experiments, two 13C-labeled metabolites circulated; one
was the infused 13C-lactate, and the other was 13C-glucose, sec-
ondarily labeled from incorporation of 13C from infused tracer
lactate. Because both label sources were taken up and oxidized
by healthy and injured brains, it was necessary to distinguish their
respective contributions to 13CO2 in jugular venous blood. We
estimated the relative contributions of 13C-labeled-lactate and
secondarily-labeled glucose carbon sources to cerebral CO2 pro-
duction by comparing the 13C isotopic enrichments of arterial
lactate (2.7%) and glucose (1.1%).24 In TBI patients, 69% of 13CO2
appearing in JB blood was from lactate oxidation and the remainder
was from the oxidation of glucose secondarily labeled with 13C in
GNG from lactate. In the control group, 90% of the 13CO2 in jug-
ular bulb blood was from lactate oxidation, and the remainder was
from the oxidation of glucose secondarily labeled. To reiterate,
aggregate results such as those in Figure 9 illustrate the role of
systemic lactate production in continuously supplying cerebral
substrates, in particular under the stress of TBI. In healthy controls
as well as TBI patients, both systemic lactate (from peripheral
glycogenolysis) and glucose (from GNG of lactate) are taken up by
the brain.
Exigencies to support cerebral functioning following severe
injury require immediate and continuous attention by health care
professionals. However, it remains that the body corpus and its
major organ systems support cerebral functioning always, making
it virtually impossible to describe the metabolic needs of the injured
brain in the absence of considering responses of the body to support
the injured brain.
Of all the responses observed in this and our companion report,24
several interactions are noteworthy. Among those are the relative
contributions of hepatic glycogenolysis and GNG from lactate
to support brain metabolism (Fig. 10). In terms of CMRgluc
( =TMUgluc), the present results (Fig. 10A and C) are consistent with
those of others obtained on healthy individuals48–50 in that the brain
accounts for 20–25% of whole body glucose disposal. That range
sets a firm basis on which to judge our result of 22% of glucose Rd
taken up by the healthy brain. As shown in Fig. 10B, following TBI,
CMRgluc decreases even though the contribution of glucose from
lactate-derived GNG increases, providing 65% of the total net glu-
cose uptake (Fig. 10F). In healthy controls, hepatic glycogenolysis
provided most glucose taken up by the brain, with GNG from lactate
contributing only 3.3% of net glucose uptake (Fig. 10C). Following
TBI, several things happened to cerebral glucose use: the percent of
whole body glucose disposal accounted for by the brain decreased
because CMRgluc decreased whereas whole body glucose Ra rose,
and the contribution of lactate to GNG quadrupled. In healthy
FIG. 9. Violin plots of 13CO2 excretion in jugular bulb ( JB)
blood. Both infused [3-13C]lactate and glucose secondarily labeled
with 13C via gluconeogenesis from lactate contributed to 13CO2 in
JB cerebral drainage. The relative isotopic enrichments of pre-
cursor pools give the contributions of lactate and glucose to JB
13CO2 in traumatic brain injury (TBI) patients (dotted lines, top)
and control subjects (solid lines, below). Solid lines represent TBI
patients (n= 12) whereas dashed lines are normal control subjects
(n = 6).
FIG. 10. Histograms of the absolute and relative contributions of gluconeogenesis (GNG) from lactate and hepatic glycogenolysis to
cerebral glucose uptake in healthy control subjects (left, panels A, C, and E), and traumatic brain injury (TBI) patients (Right, panels B,
D and F). Compared with panel A, panel B shows the decrease in cerebral metabolic rate for glucose (CMRgluc) following TBI, but an
increase contribution of GNG to CMRgluc after TBI. Compared with panel C, panel D shows the percentage of whole body glucose
disposal accounted for by brain metabolism following TBI. The relative decrease after TBI occurs because CMRgluc decreases whereas
whole body glucose production (Ra) increases. Panel D also shows the increased role of GNG in supporting CMRgluc. Panels E and F
show reversal of the relative roles of GNG from lactate and hepatic glycogenolysis in supporting CMRgluc. More than half (64%) of
glucose taken up by the traumatized brain is derived from lactate via GNG.
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controls, hepatic glycogenolysis accounted for 84% of glucose taken
up and used by the brain (Fig. 10E), and GNG from lactate con-
tributed the remainder, 16%. In contrast, following TBI, 64% of
glucose for brain metabolism was provided by GNG from lactate
(Fig. 10F), and hepatic glycogenolysis provided the remainder
(36%). This change represented a reversal of the roles of hepatic
GNG and glycogenolysis for supplying substrate to the injured brain
(Fig. 10E and F).
Glucose and lactate supply carbohydrate energy sources to the
brain, and the contributions of each to total body and cerebral
energy production vary according to condition. As was developed
(Fig. 10), the healthy brain consumes 22% of the whole body
glucose disposal (Rd), whereas the brain accounts for only 3% of
body lactate disposal in healthy individuals (not shown). How-
ever, in terms of total carbohydrate (CHO) uptake in healthy
controls, the CMRgluc (4.9 mg/100 g/min from hepatic glyco-
genolysis +GNG) accounts for 91% of the total CHO (glucose +
lactate) uptake because the TMUlac contributes 0.49 mg/100 g/
min, or 9% of total CHO uptake (Fig. 8A). Therefore, in terms of
the contributions of lactate, GNG from lactate provided 15% and
direct lactate uptake contributed 9% of total cerebral CHO use in
healthy controls. Alternatively stated, lactate contributed 24% of
the CHO energy taken up by the healthy brain, either directly
(TMU), or indirectly (the contribution of GNG from lactate to
CMRgluc) (Fig. 8C). Glucose from hepatic glycogenolysis con-
tributed the remainder.
Compared with what occurs in healthy controls, the relative role
of lactate in fueling the injured brain increases following TBI. This
is because TMUlac is not significantly affected by TBI (Fig. 5B),
whereas CMRgluc is significantly reduced (Fig. 2A). Therefore,
following TBI, the contribution of lactate approximated 10% of the
total cerebral carbohydrate uptake, whereas CMRgluc (from hepatic
glycogenolysis +GNG) remained at* 90% of total cerebral CHO
supply (Fig. 8B). And, within the contribution of glucose, GNG
from lactate contributed 58% of cerebral CHO uptake following
TBI (Fig. 8B). Following TBI, GNG from lactate accounted for
64% of CMRgluc, or 1.85 mg/100 g/min. Hence, 68% of the car-
bohydrate energy taken up and used by the injured brain came from
lactate, either directly (from TMU), or indirectly (from GNG) (Fig.
8D). With these insights, by simply summing TMUgluc and TMUlac
to estimate cerebral CHO uptake, the relative role of lactate is
underestimated from controls, and is vastly underrepresented for
TBI patients (Fig 8C and D).
Limitations
A limitation of our study imposed by concerns for informed
consent was that observations were made several days after injury,
when arterial lactate levels were presumably lower than during the
immediate post-injury period of hyperglycolysis20,32,51 (Fig. 1B).
Therefore, it may be that although cerebral lactate fractional ex-
traction was preserved following TBI (Fig. 3B), perhaps because of
increased MCT expression,19 the low glycogen reserves in muscle,
skin, liver, and other tissues limited cerebral lactate delivery days
after cerebral injury. Studies on the saturability of cerebral lactate
uptake as a function of time following injury will be necessary, but
for now, the presence of lactate fractional extraction supports the
idea of supporting the nutritive requirements of the injured brain by
supplying exogenous lactate.18
Another limitation of this study was that only small, tracer
amounts of 13C-lactate were given to TBI patients and controls,
there having been no attempt to determine the effect of raising
arterial lactate and CMRlac by exogenous [lactate] infusion. Hence,
we do not know at which blood [lactate] concentration saturation
occurred. From our previous efforts, we know that several hours of
sodium-lactate infusion at a rate sufficient to raise arterial [lactate]
to*4 mM does not raise arterial blood glucose or produce unto-
ward effects in healthy young men.10,11,13,23,43 Similarly, Bouzat
et al.46 have shown that several hours of sodium-lactate infusion at
a rate sufficient to raise arterial lactate to 4–6 mM, a rate sufficient
to deliver a majority of the carbohydrate dietary needs without a
significant change in systemic glucose, has the additional beneficial
effects of lowering intracerebral pressure in patients following
severe TBI. However, we do not know how long sodium-lactate
infusion can be maintained before untoward effects on blood pH17
or renal function occur to brain-injured persons. Moreover, there is
no reason to believe that sodium-lactate would represent the opti-
mal formulation to deliver supplemental fuels and electrolytes to
the injured brain; salts or esters of lactate and formulations con-
taining one or more other monocarboxylates delivered continu-
ously, or episodically, to achieve a target [lactate] early or late after
injury, may ultimately prove more effective in promoting favorable
patient outcomes than sodium-lactate infusion alone.
Conclusions
In summary, we corroborate previous results of depressed net
glucose uptake (CMRgluc) by the injured human brain. However,
our results obtained using glucose and lactate tracers unmask
Herculean attempts of the body to support the energy needs of the
brain flowing injury.24 Body glycogen reserves are mobilized, with
the result being high rates of systemic lactate production. Although
not directly measured in these experiments, we22,52 and others have
previously observed that resting skeletal muscles are sites of net
lactate release, and, consequently, are sources of circulating lactate.
However, it is clear also that in resting, non-exercising individuals,
diverse tissues such as the integument, contribute to the circulating
lactate load, likely through action of the sympathetic arm of the
autonomic nervous system.53–55 Although not apparent in either
blood glucose or blood lactate concentration measurements, tracer-
measured whole-body glucose and lactate turnover rates are very
high following TBI, with lactate giving rise to most glucose pro-
duction via GNG. Also, we now report that peripherally produced
lactate is available as a cerebral energy supply always, including
after TBI. Therefore, both directly via cerebral uptake, and indi-
rectly as a gluconeogenic precursor, lactate from the corpus serves
the brain’s fuel energy needs following injury. Undiminished ce-
rebral lactate fractional extraction and uptake are interpreted to
mean that arterial lactate supplementation may be used to com-
pensate for decreased CMRgluc following TBI.
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